We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Version of Boston Scientific’s Acurate Heart Valve Causes Fewer Adverse Events
New Version of Boston Scientific’s Acurate Heart Valve Causes Fewer Adverse Events
Boston Scientific’s Acurate neo2 transcatheter heart valve showed a “significantly lower” frequency of cardiac complications than earlier versions of the device, Italian researchers reported in the journal of the American College of Cardiology.